Guangzhou LBP Medicine Science & Technology Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Xiangting Cai
Chief executive officer
CN¥965.1k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.9yrs |
| CEO ownership | 35.0% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Business Is Trailing The Market But Its Shares Aren't
Feb 07
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit
Nov 06Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon
Sep 30Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%
Apr 23Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings
Mar 09CEO
Xiangting Cai (60 yo)
10.9yrs
Tenure
CN¥965,100
Compensation
Mr. Xiangting Cai serves as Chairman of the Board at Guangzhou LBP Medicine Science & Technology Co., Ltd. (formerly known as LBP Medicine Science & Technology Co., Ltd) and serves as its General Manager....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | no data | CN¥965.10k | 35.02% CN¥ 654.4m | |
| Deputy GM & Director | 4.2yrs | CN¥525.50k | 0.0089% CN¥ 165.7k | |
| Deputy GM & Director | 4.2yrs | CN¥800.90k | 0.011% CN¥ 196.2k | |
| Deputy GM & Director | 10.9yrs | CN¥693.50k | 0.013% CN¥ 245.2k | |
| Accounting Supervisor | no data | no data | no data |
4.2yrs
Average Tenure
44.5yo
Average Age
Experienced Management: 688393's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 10.9yrs | CN¥965.10k | 35.02% CN¥ 654.4m | |
| Deputy GM & Director | 4.2yrs | CN¥525.50k | 0.0089% CN¥ 165.7k | |
| Deputy GM & Director | 4.2yrs | CN¥800.90k | 0.011% CN¥ 196.2k | |
| Deputy GM & Director | 10.9yrs | CN¥693.50k | 0.013% CN¥ 245.2k | |
| Director | 7.3yrs | no data | 0.075% CN¥ 1.4m | |
| Independent Director | 4.2yrs | CN¥80.00k | no data | |
| Independent Director | 4.2yrs | CN¥80.00k | no data | |
| Director | 1.2yrs | CN¥765.20k | no data | |
| Supervisor | 1.2yrs | no data | 0.00061% CN¥ 11.4k | |
| Independent Director | 1.2yrs | no data | no data |
4.2yrs
Average Tenure
45yo
Average Age
Experienced Board: 688393's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 06:58 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Guangzhou LBP Medicine Science & Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.